Respiratory Infections News

Interim phase 3 data released by Brii Biosciences showed that the company’s monoclonal antibody combination therapy reduced the combined endpoint of COVID-19 hospitalizations and death by 78% in high-risk patients compared with placebo.

Long COVID, which the CDC defines as “new, returning, or ongoing health problems” that occur weeks after a person is infected with SARS-CoV-2, has been linked to hundreds of symptoms.

Universal testing and contact tracing failed to find evidence that near-capacity school buses were the source of SARS-CoV-2 transmission at a school in Virginia, researchers reported.

COVID-19 vaccine effectiveness declined to 66% among a cohort of health care workers after delta became the predominant SARS-CoV-2 variant, according to a report in MMWR.

Pfizer and BioNTech announced Wednesday that they are seeking FDA approval for a booster dose of their messenger RNA COVID-19 vaccine for people aged 16 years or older.

Johnson & Johnson said Wednesday that a booster dose of its COVID-19 vaccine generated a ninefold increase in antibodies among clinical trial participants compared with levels seen 28 days after the first shot.

Researchers estimated that more than 267,000 infants in low- and middle-income countries died in 2020 as a result of the economic downturn caused by the COVID-19 pandemic.

Younger individuals, particularly men aged 20 to 29 years, may be underrecognized, high-risk groups for COVID-19 infection, according to findings published in Annals of Internal Medicine.

After the FDA granted full approval to the Pfizer-BioNTech COVID-19 vaccine on Monday, the AAP strongly discouraged providers from administering it off-label to children aged younger than 12 years.

I chose ID as a medical specialty because of the intellectual stimulation and investigative nature that accompanies the study of microbes within humans.